Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

FDA approves Boehringer Ingelheim's Micardis HCT

Nov. 21, 2000

PGE1 derivatives from Taisho and use in cardiovascular disorders

Nov. 21, 2000

CB1 cannabinoid receptor activation involved in cirrhosis-associated hypotension

Nov. 21, 2000

United Therapeutics and Antigen sign distribution agreement for UT-15

Nov. 21, 2000

Reverse Na+/Ca2+ exchange inhibitor KB-R7943 studied in arrhythmia, reperfusion

Nov. 21, 2000

MCI-154 shown to increase myofilament cooperativity

Nov. 20, 2000

ET-1 antisense ODNs show antiarrhythmic effects in AMI

Nov. 20, 2000

Y-27632 explored as vasodilator for HF

Nov. 20, 2000

Early clinical data support further development of sitaxsentan for PAH

Nov. 17, 2000

AHA news: preclinical studies support use of PD-180988 for the management of pulmonary hypertension

Nov. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...